12,111 Shares in Electromed, Inc. $ELMD Purchased by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC acquired a new position in shares of Electromed, Inc. (NYSE:ELMD) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 12,111 shares of the company’s stock, valued at approximately $284,000. Janney Montgomery Scott LLC owned approximately 0.15% of Electromed at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its stake in shares of Electromed by 717.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 106,005 shares of the company’s stock worth $3,087,000 after acquiring an additional 93,030 shares during the last quarter. Hsbc Holdings PLC acquired a new position in Electromed in the 4th quarter valued at $358,000. BNP Paribas Financial Markets raised its stake in Electromed by 33.3% in the 2nd quarter. BNP Paribas Financial Markets now owns 29,916 shares of the company’s stock valued at $658,000 after purchasing an additional 7,472 shares during the last quarter. LPL Financial LLC purchased a new position in Electromed in the 4th quarter valued at $657,000. Finally, Jump Financial LLC lifted its holdings in Electromed by 49.4% in the 2nd quarter. Jump Financial LLC now owns 19,604 shares of the company’s stock valued at $431,000 after purchasing an additional 6,486 shares in the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Analyst Upgrades and Downgrades

ELMD has been the subject of a number of research reports. B. Riley Financial upped their target price on shares of Electromed from $38.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Zacks Research downgraded shares of Electromed from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $37.50.

Insider Activity

In related news, CFO Bradley M. Nagel sold 11,801 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $36.35, for a total transaction of $428,966.35. Following the completion of the sale, the chief financial officer directly owned 19,638 shares in the company, valued at approximately $713,841.30. This trade represents a 37.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO James L. Cunniff sold 9,700 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $36.50, for a total transaction of $354,050.00. Following the sale, the chief executive officer owned 147,751 shares of the company’s stock, valued at $5,392,911.50. This represents a 6.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 61,501 shares of company stock valued at $2,202,216. 10.50% of the stock is currently owned by insiders.

Electromed Stock Performance

NYSE:ELMD opened at $42.10 on Friday. Electromed, Inc. has a one year low of $17.73 and a one year high of $47.40. The stock has a market cap of $348.59 million, a PE ratio of 56.13 and a beta of 0.50. The stock has a 50 day moving average price of $39.25 and a 200 day moving average price of $30.59.

About Electromed

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.